Physician profile
Daniel Shein
NPI 1518264449
$5,054.79
in general payments reported to CMS, 2019-2025
14 companies · $1,807 in 2025
The $1,807 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $324 · 2021: $311 · 2022: $337 · 2023: $1,580 · 2024: $360 · 2025: $1,807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,197 · Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,196.80 |
| Food and Beverage | $1,550.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexxt Spine LLC | $1,285.07 | 2025 | Nexxt Spine Technology |
| Integrity Implants INC. Dba Accelus | $1,212.15 | 2023 | |
| Stryker Corporation | $1,127.00 | 2019-2025 | Mako, Accolade |
| Orthofix Medical, INC. | $355.89 | 2020-2023 | |
| Horizon Therapeutics Plc | $278.80 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $234.41 | 2024 | |
| Highridge Medical LLC | $125.54 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Smith+Nephew, INC. | $112.75 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $100.59 | 2022-2023 | Seglentis |
| Bioventus LLC | $70.00 | 2019 | |
| Surgalign Spine Technologies, INC. | $50.06 | 2020-2021 | |
| Depuy Synthes Sales INC. | $44.15 | 2019-2021 | |
| Royal Biologics, INC. | $40.94 | 2023 | |
| Medtronic USA, INC. | $17.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Shein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.